# CRP /Albumin Ratio and Neutrophil Lymphocyte Ratio in Predicting Activity in IBD Patients

> **NCT06750315** · — · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 35 (estimated)

## Conditions studied

- Inflammatory Bowel Disease (IBD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06750315
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06750315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06750315, "CRP /Albumin Ratio and Neutrophil Lymphocyte Ratio in Predicting Activity in IBD Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06750315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*